Alisah Hussain, Yaw Asare-Amankwah, Nikolaos S Lymperopoulos, M Julie Thornton, Kirsten Riches-Suman
{"title":"Smooth muscle cells from skin perforator vessels as a new tool for vascular research.","authors":"Alisah Hussain, Yaw Asare-Amankwah, Nikolaos S Lymperopoulos, M Julie Thornton, Kirsten Riches-Suman","doi":"10.1007/s10974-025-09704-z","DOIUrl":null,"url":null,"abstract":"<p><p>Vascular smooth muscle cells (SMC) comprise the medial layer of blood vessels and are responsible for maintaining vascular tone. Ordinarily quiescent and contractile, SMC can dedifferentiate into different phenotypes following injury or in disease states such as atherosclerosis and are thus valuable research tools for examining these conditions. The isolation of commonly used SMC types, such as those from the aorta or saphenous vein (SV), require clinical links or commercial supply and are rarely pathology-free. The skin is highly vascularised with perforator (Perf) vessels that protrude through the skin layers to feed the tissue. Whilst these vessels can be sourced from clinical procedures (e.g. reconstructive surgery), they are also available from elective cosmetic procedures such as abdominoplasty which could provide blood vessels unaffected by an underlying pathology. This paper describes the isolation of Perf-SMC for the first time, using a cost-effective explant technique. Explanted cells were confirmed as SMC by co-staining for alpha smooth muscle actin and smooth muscle myosin heavy chain. Phenotypic characteristics of Perf-SMC (cell morphology, proliferation, and multinucleation) were comparable to those from commonly used SMC from alternative vascular sources (SV-SMC and umbilical artery SMC). Furthermore, Perf-SMC were stable in culture up until at least passage 9 with no alteration in morphological characteristics or evidence of replication-induced phenotypic change. In summary, this paper describes an effective, efficient and low-cost method for isolating SMC from skin perforator vessels that may be a useful tool for the future examination of SMC behaviour from both pathological and healthy skin.</p>","PeriodicalId":16422,"journal":{"name":"Journal of Muscle Research and Cell Motility","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Muscle Research and Cell Motility","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10974-025-09704-z","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Vascular smooth muscle cells (SMC) comprise the medial layer of blood vessels and are responsible for maintaining vascular tone. Ordinarily quiescent and contractile, SMC can dedifferentiate into different phenotypes following injury or in disease states such as atherosclerosis and are thus valuable research tools for examining these conditions. The isolation of commonly used SMC types, such as those from the aorta or saphenous vein (SV), require clinical links or commercial supply and are rarely pathology-free. The skin is highly vascularised with perforator (Perf) vessels that protrude through the skin layers to feed the tissue. Whilst these vessels can be sourced from clinical procedures (e.g. reconstructive surgery), they are also available from elective cosmetic procedures such as abdominoplasty which could provide blood vessels unaffected by an underlying pathology. This paper describes the isolation of Perf-SMC for the first time, using a cost-effective explant technique. Explanted cells were confirmed as SMC by co-staining for alpha smooth muscle actin and smooth muscle myosin heavy chain. Phenotypic characteristics of Perf-SMC (cell morphology, proliferation, and multinucleation) were comparable to those from commonly used SMC from alternative vascular sources (SV-SMC and umbilical artery SMC). Furthermore, Perf-SMC were stable in culture up until at least passage 9 with no alteration in morphological characteristics or evidence of replication-induced phenotypic change. In summary, this paper describes an effective, efficient and low-cost method for isolating SMC from skin perforator vessels that may be a useful tool for the future examination of SMC behaviour from both pathological and healthy skin.
期刊介绍:
The Journal of Muscle Research and Cell Motility has as its main aim the publication of original research which bears on either the excitation and contraction of muscle, the analysis of any one of the processes involved therein, the processes underlying contractility and motility of animal and plant cells, the toxicology and pharmacology related to contractility, or the formation, dynamics and turnover of contractile structures in muscle and non-muscle cells. Studies describing the impact of pathogenic mutations in genes encoding components of contractile structures in humans or animals are welcome, provided they offer mechanistic insight into the disease process or the underlying gene function. The policy of the Journal is to encourage any form of novel practical study whatever its specialist interest, as long as it falls within this broad field. Theoretical essays are welcome provided that they are concise and suggest practical ways in which they may be tested. Manuscripts reporting new mutations in known disease genes without validation and mechanistic insight will not be considered. It is the policy of the journal that cells lines, hybridomas and DNA clones should be made available by the developers to any qualified investigator. Submission of a manuscript for publication constitutes an agreement of the authors to abide by this principle.